Literature DB >> 11341865

Mesenteric Vascular Disease.

Bruce H. Gray1, Timothy M. Sullivan.   

Abstract

The clinical presentation of mesenteric ischemia depends on the site, grade, and cause of vascular obstruction; the degree of collateralization; and the stage of disease. Patients in the early stages of ischemia typically have abdominal pain out of context with an unimpressive abdominal examination. It is during this stage that medical and endovascular techniques can be most effective. After signs of peritonitis are present (signaling bowel infarction), surgical exploration and bowel resection are necessary. Chronic mesenteric ischemia induced by stenotic arteriosclerosis should be treated with percutaneous transluminal angioplasty and stenting (PTAS). Chronic mesenteric arterial occlusions are better handled with bypass surgery. Acute embolic or thrombotic ischemia is surgically treated after medical resuscitation. Endovascular techniques may be applicable in selected patients (usually in those with subacute symptoms), but thrombolytic therapy should be avoided if intestinal infarction is suspected. Non-occlusive mesenteric ischemia requires a rapid correction of the predisposing hypotension or sepsis followed by papaverine infusion into the superior mesenteric artery. Celiac artery compression syndrome requiring treatment is best treated with surgical release of the median arcuate ligament; PTAS should not be performed. Mesenteric venous occlusion should be treated with anticoagulation. Surgical exploration and bowel resection is necessary in patients presenting with acute signs and symptoms, reserving thrombolytic therapy for early, mildly symptomatic, thromboses in whom there is no contraindication to thrombolysis.

Entities:  

Year:  2001        PMID: 11341865     DOI: 10.1007/s11936-001-0038-1

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  20 in total

Review 1.  Nonocclusive mesenteric ischemia.

Authors:  L J Brandt; S J Boley
Journal:  Annu Rev Med       Date:  1991       Impact factor: 13.739

Review 2.  Pathophysiology of mesenteric ischemia.

Authors:  A Patel; R N Kaleya; R J Sammartano
Journal:  Surg Clin North Am       Date:  1992-02       Impact factor: 2.741

Review 3.  Intestinal (mesenteric) vasculopathy. I. Acute superior mesenteric arteriopathy and venopathy.

Authors:  M S Cappell
Journal:  Gastroenterol Clin North Am       Date:  1998-12       Impact factor: 3.806

4.  New concepts in the management of emboli of the superior mesenteric artery.

Authors:  S J Boley; F R Feinstein; R Sammartano; L J Brandt; S Sprayregen
Journal:  Surg Gynecol Obstet       Date:  1981-10

5.  Elective surgical treatment of symptomatic chronic mesenteric occlusive disease: early results and late outcomes.

Authors:  R B Mateo; P J O'Hara; N R Hertzer; E J Mascha; E G Beven; L P Krajewski
Journal:  J Vasc Surg       Date:  1999-05       Impact factor: 4.268

Review 6.  Mesenteric venous thrombosis: still a lethal disease in the 1990s.

Authors:  R Y Rhee; P Gloviczki; C T Mendonca; T M Petterson; R D Serry; M G Sarr; C M Johnson; T C Bower; J W Hallett; K J Cherry
Journal:  J Vasc Surg       Date:  1994-11       Impact factor: 4.268

7.  Intestinal infarction secondary to mesenteric venous thrombosis: CT-pathologic correlation.

Authors:  J Y Kim; H K Ha; J Y Byun; J M Lee; B K Yong; I C Kim; J Y Lee; W S Park; K S Shinn
Journal:  J Comput Assist Tomogr       Date:  1993 May-Jun       Impact factor: 1.826

8.  The clinical course of asymptomatic mesenteric arterial stenosis.

Authors:  J H Thomas; K Blake; G E Pierce; A S Hermreck; E Seigel
Journal:  J Vasc Surg       Date:  1998-05       Impact factor: 4.268

9.  Mesenteric venous thrombosis--1911 to 1984.

Authors:  R A Abdu; B J Zakhour; D J Dallis
Journal:  Surgery       Date:  1987-04       Impact factor: 3.982

10.  Improved outcome by identification of high-risk nonocclusive mesenteric ischemia, aggressive reexploration, and delayed anastomosis.

Authors:  D Ward; A M Vernava; D L Kaminski; T Ure; G Peterson; P Garvin; T W Arends; W E Longo
Journal:  Am J Surg       Date:  1995-12       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.